Clinical and Translational Radiation Oncology

Article	Citations
Influence of intestinal microbial metabolites on the abscopal effect after radiation therapy combined with immune checkpoint inhibitors	31
Stabilised Hyaluronic Acid (sHA) gel as a novel marker for breast cancer tumour bed cavity: Surgical feasibility	31
Machine learning for dose-volume histogram based clinical decision-making support system in radiation therapy plans for brain tumors	25
Uterus motion analysis for radiotherapy planning optimization. The innovative contribution of on-board hybrid MR imaging	23
Measuring patient reported outcomes in brachytherapy: Why we should do it and more importantly how	18
Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States – Understanding the transition to adaptive, ultra-hypofractionated treatments	17
Oxygen-enhanced MRI and radiotherapy in patients with oropharyngeal squamous cell carcinoma	16
Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12)	16
Avoiding prostate bed radiation for the PSMA-PET detected nodal recurrence patient post prostatectomy	16
Blood-brain barrier permeability following conventional photon radiotherapy – A systematic review and meta-analysis of clinical and preclinical studies	15
Association between radiotherapy protocol variations and outcome in the CONVERT trial	15
Systemic therapy escalation after stereotactic body radiation therapy for oligometastatic hormone-sensitive prostate cancer	13
CD8-positive lymphocyte infiltration as a marker of anti-tumor immune response in rectal cancer: pre- and post-neoadjuvant radiotherapy comparison	13
Developing and validating a simple urethra surrogate model to facilitate dosimetric analysis to predict genitourinary toxicity	12
Longitudinal trajectory of quality of life for patients with melanoma brain metastases: A secondary analysis from a whole brain radiotherapy randomized clinical trial	12
A fully automated machine-learning-based workflow for radiation treatment planning in prostate cancer	12
Effectiveness, toxicity and impact on quality of life of high-dose-rate brachytherapy delivered in two fractions as monotherapy in patients with prostate cancer	12
Toxicity profile and Patient-Reported outcomes following salvage Stereotactic Ablative Radiation Therapy to the prostate Bed: The POPART multicentric prospective study	12
Bulky non-small cell lung cancer treated with two-field robust proton lattice boost followed by conventional chemoradiation	11
Long-term outcomes of more than a decade treating patients with stereotactic body radiation therapy for hepatocellular carcinoma	11
Predicting radiation-induced hypothyroidism in nasopharyngeal carcinoma patients using a deep learning model	11
Bladder-preserving radiation therapy for patients with locally advanced and node-positive bladder cancer	10
Feasibility of tumour-focused adaptive radiotherapy for bladder cancer on the MR-linac	10
Radiation response assessment of organoids derived from patients with pancreatic cancer	10
Patient reported outcomes for quality of life (QOL) by Expanded Prostate Cancer Index (EPIC) on average 15 years post treatment	9

Contemporary use and outcomes of radiation and chemotherapy for unresectable pancreatic cancer	9
Stereotactic ablative radiotherapy for treating primary head and neck cancer and locoregional recurrence: A comprehensive review of the literature	9
Early circulating tumor DNA dynamics at the commencement of curative-intent radiotherapy or chemoradiotherapy for NSCLC	8
Letter to the editor: Reply to Chen et al.	8
Predicting late renal toxicity using a two-component repair model among pediatric patients receiving total body irradiation for stem cell transplant	8
Artificial intelligence to predict outcomes of head and neck radiotherapy	8
Metastases-directed radiotherapy in castration resistant oligo metastatic prostate cancer: A multicentric retrospective study from the French group COLib	8
Changes in prostate volume during prostate SBRT delivered on an MR-Linac and correlation with acute toxicity	8
Comparing supervised and semi-supervised machine learning approaches in NTCP modeling to predict complications in head and neck cancer patients	8
Outcomes and predictors of response to fractionated radiotherapy as primary treatment for intracranial meningiomas	8
MRI-guided radiotherapy in twenty fractions for localised prostate cancer; results from the MOMENTUM study	8
Comparison of simultaneous integrated tumor bed boost and sequential boost during hypofractionated whole-breast irradiation after breast-conserving surgery	8
Assessment of the impact of age on DIBH in radiotherapy based on the prospective GATTUM and B-REST trials	8
Simulation-free palliative radiotherapy using diagnostic CT scans– is less more? A systematic review	7
Investigation of the physiological response of radiation-induced cystitis patients using hyperbaric oxygen	7
Comparison of 18F-FET-PET- and MRI-based target definition for re-irradiation treatment of recurrent diffuse glioma	7
Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration‐resistant prostate cancer patients – A closer inspection will improve your vision	7
Acute toxicity patterns and their management after moderate and ultra- hypofractionated radiotherapy for prostate cancer: A prospective cohort study	7
Comparative effectiveness of new treatment modalities for localized prostate cancer through patient-reported outcome measures	7
Setting the stage: The opening act of preoperative SRS for brain metastases	7
Adaptive FDG-PET/CT guided dose escalation in head and neck squamous cell carcinoma: Late toxicity and oncologic outcomes (The ADMIRE study)	7
Integrative prediction model for radiation pneumonitis incorporating genetic and clinical-pathological factors using machine learning	7
Risk of stroke-specific mortality after radiotherapy in patients with primary brain tumours	6
Clinical management of oligometastatic cancer: Applying multidisciplinary tumor board recommendations in practice	6
Acute toxicities in proton therapy for head and neck cancer – A matched analysis of the DAHANCA 35 feasibility study	6
Feasibility of low-dose radiotherapy for patients with stage I/II extranodal NK-/T-cell lymphoma, nasal type achieving complete response after l-asparaginase-containing chemotherapy	6
The prognostic utility of IGF-1 in hepatocellular carcinoma treated with stereotactic body radiotherapy	6
Randomized clinical trial of tissue equivalent bolus prescription in postmastectomy radiotherapy stratified by skin involvement status	6
Clinical outcomes of esophageal squamous cell carcinoma in patients with cirrhosis	6
Defining radio-recurrent intra-prostatic target volumes using PSMA-targeted PET/CT and multi-parametric MRI	6
Complications leading to hospitalisation 12 months after brachytherapy or high-intensity focused ultrasound for localized prostate cancer: French national from the PMSI-MCO data, 2019 and 2020	6
Morphological changes after cranial fractionated photon radiotherapy: Localized loss of white matter and grey matter volume with increasing dose	6
Corrigendum to “Bridging the care gap: patients’ needs and experiences regarding shared decision-making in radiotherapy” [Clin. Translat. Radiat. Oncol. (2025) 100897]	6
Immunohistochemical analyses of paraffin-embedded sections after primary surgery or trimodality treatment in esophageal carcinoma	6
Concurrent palliative radiation with pembrolizumab for platinum-refractory urothelial carcinoma is associated with improved overall survival	6
Simultaneous integrated boost and protection proton beam therapy approach for hepatocellular carcinoma	6
In regard to Kim et al	6
The first real-world study on the role of carbon ion radiotherapy for oligo-metastatic, persistent, or recurrent (MPR) ovarian/fallopian tube cancer	6
Quantifying radiation-induced breast fibrosis by shear-wave elastography in patients with breast cancer: A 12-months-follow-up data of a prospective study	6
Changes in splenic volumes following stereotactic ablative radiotherapy (SABR) to adrenal tumors	5
A prospective study assessing the pattern of response of local disease at DCE-MRI after salvage radiotherapy for prostate cancer	5
Fractionated stereotactic radiotherapy of intracranial postoperative cavities after resection of brain metastases – Clinical outcome and prognostic factors	5
The carbon footprint of external beam radiotherapy and its impact in health technology assessment	5
Cetuximab, gemcitabine and radiotherapy in locally advanced pancreatic cancer: Long-term results of the randomized controlled phase II PARC trial	5
Refractory ventricular tachycardia treated by a second session of stereotactic arrhythmia radioablation	5
Artificial intelligence guided physician directive improves head and neck planning quality and practice Uniformity: A prospective study	5
Primary site stereotactic ablative body radiotherapy in localized, recurrent, and metastatic renal cell carcinoma	5
MucoUp® as a spacer in brachytherapy for uterine cervical cancer: A first-in-human experience	5
Acute and late toxicity patterns of moderate hypo-fractionated radiotherapy for prostate cancer: A systematic review and meta-analysis	5
Does a peer review group consensus process for MR-Linac patients affect clinical care? Evaluation of impact and feasibility	5

Deterioration of pancreatic exocrine function in carbon ion radiotherapy for pancreatic cancer	5
Salvage LATTICE radiotherapy for a growing tumour despite conventional radio chemotherapy treatment of lung cancer	5
Multidisciplinary Treatment of Non-Spine Bone Metastases: Results of a Modified Delphi Consensus Process	5
Acute toxicity and quality of life in dose-escalated proton reirradiation for locally recurrent rectal cancer: The prospective ReRad II trial	5
Outcomes and toxicities in oligometastatic patients treated with stereotactic body radiotherapy for adrenal gland metastases: A multi-institutional retrospective study	5
Postoperative complications after esophagectomy for cancer, neoadjuvant chemoradiotherapy compared to neoadjuvant chemotherapy: A single institutional cohort study	5
The need for consensus on delineation and dose constraints of dentofacial structures in paediatric radiotherapy: Outcomes of a SIOP Europe survey	5
Predicting the benefit of stereotactic body radiotherapy of colorectal cancer metastases	5
Access to brachytherapy treatment for cervical cancer management in Africa	5
Impact of pretreatment second look 18FDG-PET/CT on stage and treatment changes in head and neck cancer	5
Interrater agreement of contouring of the neurovascular bundles and internal pudendal arteries in neurovascular-sparing magnetic resonance-guided radiotherapy for localized prostate cancer	5
The role of radiotherapy in the management of metastatic rectal cancer: A narrative review on the opportunities for non-operative management and organ preservation	4
Reproducibility of Deep-Inspiration Breath Hold treatments on Halcyon™ performed using the first clinical version of AlignRT InBore™: Results of CYBORE study	4
Bridging the care gap: patients’ needs and experiences regarding shared decision-making in radiotherapy	4
Letter to the Editor	4
Health care system factors associated with receipt of treatment and treatment intent in stage III non-small cell lung cancer: A population-based study in Ontario	4
Determining risk and predictors of head and neck cancer treatment-related lymphedema: A clinicopathologic and dosimetric data mining approach using interpretable machine learning and ensemble feature	4
Prospective radiotherapy quality Assurance leads to delineation guideline refinements for recurrent rectal cancer: Experience from the PelvEx II study	4
Cosmetic outcome in patients with early stage breast cancer after accelerated partial breast irradiation using intraoperative or external beam radiotherapy	4
Urethra-sparing prostate cancer radiotherapy: Current practices and future insights from an international survey	4
GI factors, potential to predict prostate motion during radiotherapy; a scoping review	4
Enhancing radiotherapy outcomes in rectal cancer: A systematic review of targeting hypoxia-induced radioresistance	4
Development and validation of cost-effective multi-sample hypoxia chambers for proton ultra-high dose rate organoid irradiations	4
Supraventricular cardiac conduction system exposure in breast cancer patients treated with radiotherapy and association with heart and cardiac chambers doses	4
Irradiation of localized prostate cancer in the elderly: A systematic literature review	4
C. elegans: A potent model for high-throughput screening experiments investigating the FLASH effect	4
Reirradiation with stereotactic radiosurgery for vestibular schwannomas – a systematic review and meta-analysis	4
Comparing pre-operative versus post-operative single and multi-fraction stereotactic radiotherapy for patients with resectable brain metastases	4
Clinical outcomes and risk factors for local failure and visual impairment in patients treated with Ru-106 brachytherapy for uveal melanoma	4
Pelvic insufficiency fractures after intensity modulated radiation therapy combined with chemotherapy for cervix carcinoma: Incidence and impact of bone mineral density	4
Time- and dose-dependent volume decreases in subcortical grey matter structures of glioma patients after radio(chemo)therapy	4
A GORTEC survey on low-risk CTV-P2 delineation in head and neck cancers	4
Postoperative radiotherapy alone is as effective as postoperative chemoradiotherapy in patients with pT4aN0 gingival cancer with negative surgical margins	4
Stereotactic radiosurgery and combined immune checkpoint therapy with ipilimumab and nivolumab in patients with melanoma brain metastases: A retrospective monocentric toxicity analysis	4
Outcomes and predictive factors after second stereotactic radiosurgery for refractory trigeminal neuralgia	4
Optimal and actual rates of Stereotactic Ablative Body Radiotherapy (SABR) utilisation for primary lung cancer in Australia	4
Mepitel® film versus standard care for the prevention of skin toxicity in breast cancer patients treated with adjuvant radiotherapy: A randomized controlled trial	4
Thyroid volume changes following adjuvant radiation therapy for breast cancer	4
#radonc: Growth of the global radiation oncology Twitter network	4
MAPK11 (p38β) is a major determinant of cellular radiosensitivity by controlling ionizing radiation-associated senescence: An in vitro study	4
Cleaning radiotherapy contours for radiomics studies, is it worth it? A head and neck cancer study	4
Cervical body composition on radiotherapy planning computed tomography scans predicts overall survival in glioblastoma patients	4
Helical tomotherapy for post-mastectomy radiation therapy with or without breast implant: a single institution experience	4
Real-world utilisation of brachytherapy boost and patient-reported functional outcomes in men who had external beam radiation therapy for prostate cancer in Australia	3
Late Adverse Health Outcomes and Quality of Life after curative radiotherapy + long-term ADT in Prostate Cancer Survivors: Comparison with men from the general population	3
Who should receive single-fraction palliative radiotherapy for gastric cancer bleeding?: An exploratory analysis of a multicenter prospective observational study (JROSG 17-3)	3
Feasibility and safety of single-fraction sub-ablative radiotherapy with systemic therapy in colorectal cancer patients with ≤ 10 metastases: A multicenter pilot study (NCT05375708)	3
Quality-of-life and toxicity in cancer patients treated with multiple courses of radiation therapy	3
PSMA response evaluation in follow-up PSMA-PET/CT after stereotactic ablative body radiotherapy (SABR) for oligometastases in prostate cancer	3
Mid-treatment adaptive planning during thoracic radiation using 68 Ventilation-Perfusion Positron emission tomography	3
Large language models for pretreatment education in pediatric radiation oncology: A comparative evaluation study	3
Online adaptive radiotherapy for head and neck cancers on the MR linear Accelerator: Introducing a novel modified Adapt-to-Shape approach	3
Ultra-hypofractionated one-week locoregional radiotherapy for patients with early breast cancer: Acute toxicity results	3
Unmasking enteritis: reply to commentary titled “Clarifying Gastrointestinal toxicity attribution in WP-SBRT: A commentary on Dinesan et al. and proposal of a bladder-bowel displacement index”	3
SABR for oligometastatic renal cell carcinoma	3
Dynamic tumor-tracking stereotactic body radiotherapy with real-time monitoring of liver tumors using a gimbal-mounted linac: A multi-institutional phase II study	3
Exploring causes and consequences of early discontinuation of durvalumab after chemoradiotherapy for non-small cell lung cancer	3
Adjuvant PD-1 antibody in recurrent, previously irradiated oral cavity cancer treated with salvage surgery	3
Elective pelvic nodal irradiation in the setting of ultrahypofractionated versus moderately hypofractionated and conventionally fractionated radiotherapy for prostate cancer: Outcomes from 3 prospecti	3
PD-1 and PD-L1 expression predict regression and prognosis following neoadjuvant radiochemotherapy of oesophageal adenocarcinoma	3
Adaptive radiotherapy for oropharyngeal cancer with daily adapt-to-shape workflow on 1.5 T MRI-linac: Preliminary outcomes and comparison with helical tomotherapy	3
Outcomes of Isocitrate Dehydrogenase Wild Type Glioblastoma after Re-irradiation	3
Comparison of four-year toxicities and local control of ultra-hypofractionated vs moderate-hypofractionated image guided prostate radiation with HDR brachytherapy boost: A phase I-II single institutio	3
Exposure of the heart and cardiac valves in women irradiated for breast cancer 1970–2009	3
Online CBCT-based adaptive radiation with reduced PTV margins for prostate cancer: Does reference plan comparison tell the whole story?	3
From pre-clinical studies to human treatment with proton-minibeam radiation therapy: adapted Idea, Development, Exploration, Assessment and Long-term evaluation (IDEAL) framework for innovation in rad	3
External validation of pulmonary radiotherapy toxicity models for ultracentral lung tumors	3
Radiotherapy-induced Hypothalamic-Pituitary axis dysfunction in adult Brain, head and neck and skull base tumor patients – A systematic review and Meta-Analysis	3
Incidental dose distribution to contralateral internal mammary nodes in breast cancer patients undergoing adjuvant radiotherapy	3
Biopsy-derived oral keratinocytes – A model to potentially test for oral mucosa radiation sensitivity	3
Impact of endorectal filling on interobserver variability of MRI based rectal primary tumor delineation	3
Assessing concordance between patient-reported and investigator-reported CTCAE after proton beam therapy for prostate cancer	3
The value of plasma hypoxia markers for predicting imaging-based hypoxia in patients with head-and-neck cancers undergoing definitive chemoradiation	3
Design and evaluation of a deep learning-based automatic segmentation of maxillary and mandibular substructures using a 3D U-Net	3
Institutional experience of using active breathing control for paediatric and teenage patients receiving thoraco-abdominal radiotherapy	3
Salvage low-dose-rate brachytherapy for locally recurrent prostate cancer after definitive irradiation	3
Helical tomotherapy craniospinal irradiation in primary brain tumours: Toxicities and outcomes in a peadiatric and adult population	3
Patterns of locoregional recurrences and suggestion of the clinical target volume in resected perihilar extrahepatic cholangiocarcinoma	3
Splenic irradiation contributes to grade ≥ 3 lymphopenia after adjuvant chemoradiation for stomach cancer	3
Postoperative SBRT in the treatment of early-stage oropharyngeal and oral cavity cancers with high-risk margins: A dosimetric comparison of volumetric modulated arc therapy with or without non-coplana	3

The oxygen puzzle in FLASH radiotherapy: A comprehensive review and experimental outlook	3
Adaptive radiotherapy for breast cancer	3
Reply to: Comment on “Repeated HyperArc radiosurgery for recurrent intracranial metastases and dosimetric analysis of recurrence pattern to account for diffuse dose effect on microscopical disease”	3
Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer after FOLFIRINOX chemotherapy	3
Salvage radiotherapy for relapsed/refractory non‐Hodgkin lymphoma following CD19 chimeric antigen receptor T-cell (CART) therapy	3
Personalized neck irradiation guided by sentinel lymph node biopsy in patients with squamous cell carcinoma of the oropharynx, larynx or hypopharynx with a clinically negative neck: (Chemo)radiotherap	3
An exploratory analysis of MR-guided fractionated stereotactic radiotherapy in patients with brain metastases	3